BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34771720)

  • 1. Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation.
    Crocetti L; Bozzi E; Scalise P; Bargellini I; Lorenzoni G; Ghinolfi D; Campani D; Balzano E; De Simone P; Cioni R
    Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt.
    Shaker MK; Montasser IF; Sakr M; Elgharib M; Dabbous HM; Ebada H; Dorry AE; Bahaa M; Meteini ME
    J Hepatocell Carcinoma; 2018; 5():29-36. PubMed ID: 29520343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria.
    Degroote H; Piñero F; Costentin C; Notarpaolo A; Boin IF; Boudjema K; Baccaro C; Chagas AL; Bachellier P; Ettorre GM; Poniachik J; Muscari F; Di Benedetto F; Duque SH; Salame E; Cillo U; Gadano A; Vanlemmens C; Fagiuoli S; Rubinstein F; Burra P; Cherqui D; Silva M; Van Vlierberghe H; Duvoux C;
    JHEP Rep; 2021 Oct; 3(5):100331. PubMed ID: 34485882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Pretransplant Treatments for Patients with Hepatocellular Carcinoma Waiting for Liver Transplantation.
    Ogawa K; Takada Y
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.
    Pompili M; Francica G; Ponziani FR; Iezzi R; Avolio AW
    World J Gastroenterol; 2013 Nov; 19(43):7515-30. PubMed ID: 24282343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging to liver transplantation in HCC patients.
    Kollmann D; Selzner N; Selzner M
    Langenbecks Arch Surg; 2017 Sep; 402(6):863-871. PubMed ID: 28755240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular Carcinoma and Liver Transplantation: Changing Patterns and Practices.
    Rich NE; Parikh ND; Singal AG
    Curr Treat Options Gastroenterol; 2017 Jun; 15(2):296-304. PubMed ID: 28425018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
    Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB
    J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loco-regional hepatocellular carcinoma treatment services as a bridge to liver transplantation.
    Schmitz S; Lurje G; Ulmer F; Andert A; Bruners P; Schulze-Hagen M; Neumann U; Schoening W
    Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):228-236. PubMed ID: 30718181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loco-regional therapies for patients with hepatocellular carcinoma awaiting liver transplantation: Selecting an optimal therapy.
    Byrne TJ; Rakela J
    World J Transplant; 2016 Jun; 6(2):306-13. PubMed ID: 27358775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of organ transplantation in the treatment of malignancies: hepatocellular carcinoma as the most common tumour treated with transplantation.
    Végso G; Görög D; Fehérvári I; Nemes B; Doros A; Langer RM; Kóbori L
    Pathol Oncol Res; 2012 Jan; 18(1):1-10. PubMed ID: 21901276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.
    Agopian VG; Harlander-Locke MP; Ruiz RM; Klintmalm GB; Senguttuvan S; Florman SS; Haydel B; Hoteit M; Levine MH; Lee DD; Taner CB; Verna EC; Halazun KJ; Abdelmessih R; Tevar AD; Humar A; Aucejo F; Chapman WC; Vachharajani N; Nguyen MH; Melcher ML; Nydam TL; Mobley C; Ghobrial RM; Amundsen B; Markmann JF; Langnas AN; Carney CA; Berumen J; Hemming AW; Sudan DL; Hong JC; Kim J; Zimmerman MA; Rana A; Kueht ML; Jones CM; Fishbein TM; Busuttil RW
    Ann Surg; 2017 Sep; 266(3):525-535. PubMed ID: 28654545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria-In Patients Waiting for Liver Transplantation.
    Lai Q; Vitale A; Iesari S; Finkenstedt A; Mennini G; Onali S; Hoppe-Lotichius M; Manzia TM; Nicolini D; Avolio AW; Mrzljak A; Kocman B; Agnes S; Vivarelli M; Tisone G; Otto G; Tsochatzis E; Rossi M; Viveiros A; Ciccarelli O; Cillo U; Lerut J;
    Liver Transpl; 2019 Jul; 25(7):1023-1033. PubMed ID: 31087772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis on intention-to-treat outcomes.
    Di Martino M; Ferraro D; Pisaniello D; Arenga G; Falaschi F; Terrone A; Maniscalco M; Galeota Lanza A; Esposito C; Vennarecci G
    J Hepatobiliary Pancreat Sci; 2023 Apr; 30(4):429-438. PubMed ID: 36207763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging locoregional treatment prior to liver transplantation for cirrhotic patients with hepatocellular carcinoma within the Milan criteria: a systematic review and meta-analysis.
    Kostakis ID; Dimitrokallis N; Iype S
    Ann Gastroenterol; 2023; 36(4):449-458. PubMed ID: 37396004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis.
    Sourianarayanane A; El-Gazzaz G; Sanabria JR; Menon KV; Quintini C; Hashimoto K; Kelly D; Eghtesad B; Miller C; Fung J; Aucejo F
    HPB (Oxford); 2012 May; 14(5):325-32. PubMed ID: 22487070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downstaging Therapies for Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation: A Systematic Review and Meta-Analysis on Intention-to-Treat Outcomes.
    Di Martino M; Vitale A; Ferraro D; Maniscalco M; Pisaniello D; Arenga G; Falaschi F; Terrone A; Iacomino A; Galeota Lanza A; Esposito C; Cillo U; Vennarecci G
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridging patients with hepatocellular cancer waiting for liver transplant: all the patients are the same?
    Coletta M; Nicolini D; Benedetti Cacciaguerra A; Mazzocato S; Rossi R; Vivarelli M
    Transl Gastroenterol Hepatol; 2017; 2():78. PubMed ID: 29034351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.